The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,174.00
Bid: 1,179.00
Ask: 1,184.00
Change: 20.00 (1.73%)
Spread: 5.00 (0.424%)
Open: 1,134.00
High: 1,188.00
Low: 1,134.00
Prev. Close: 1,154.00
FEVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Statement

25 May 2023 07:00

RNS Number : 5765A
Fevertree Drinks PLC
25 May 2023
 

Fever-Tree Drinks plc

TRADING UPDATE

 

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces a trading update ahead of its Annual General Meeting ("AGM"), which is being held today at 11.30am BST.

Fever-Tree has made a good start to the year, trading in-line with the expectations set out at our FY22 Results.

UK

· Fever-Tree recorded its highest ever value share in the On-Trade during a first quarter trading period; c.6% higher than our share in Q1 2020[1]. We expect our Off-Trade sales to build in momentum as the year progresses and overall, we are trading in line with expectations in the UK.

· We look forward to the key summer trading period, with multiple activations planned across our portfolio and are seeing an encouraging performance from our new Adult Soft range.

· We continue to innovate and broaden our portfolio of drinks, launching our range of cocktail mixers across both channels at the beginning of Q2, with strong interest from our customers and activations planned over the summer.

US

· The US has had a strong start to the year in both the On- and Off-Trade, with good value and volume growth across all categories, with particularly strong growth in Flavoured Sparkling and Club Soda[2].

· Our flavour and format innovations are gaining traction quickly, with cocktail mixers, Blood Orange Ginger Beer, and our can packs starting to contribute meaningfully to total growth.

Europe

· In Europe, Fever-Tree continues to gain value share of the premium mixer category at retail, with particularly encouraging growth in Italy and France[3].

· This year we are excited to launch our Sparkling Pink Grapefruit into the On-Trade across Europe, expanding our portfolio to lighter summer drinks, after being encouraged by its success in the US.

ROW

· We continue to make good sales and operational progress across our RoW regions.

· The transition to our new distribution partner in Australia is progressing well and due to be finalised during the summer. Whilst our first half results will reflect an inventory buy-back as part of the transition, we are confident of a strong second half performance in this market.

FY23 outlook

We are confident that the brand will continue to deliver strong revenue growth as we start our key summer trading period and therefore reiterate our top-line guidance range as set out in March at £390m to £405m.

Whilst inflationary cost pressures remain elevated, the Group continues to be focused on delivering initiatives to mitigate these costs and expects to drive margin improvements as we progress through the year, which means we're on-track to deliver EBITDA in-line with our guidance range of £36m to £42m for 2023.

For more information please contact:

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)7435 828 138

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

 

Nominated Advisor and Broker - Investec Bank plc

David Flin I Alex Wright I +44 (0)20 7597 5970

Corporate Broker - Morgan Stanley & Co. International plc

Andrew Foster I Jessica Pauley I +44 (0)20 7425 8000

Financial PR advisers - FGS Global

Faeth Birch +44 (0)7768 943 171 I Anjali Unnikrishnan +44 (0)7826 534 233

 

 

Notes to the Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers by retail sales value, with distribution to over 85 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

 

 

 


[1] CGA Q1 2023

[2] Nielsen Q1 2023

[3] Nielsen Q1 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUSAKROWUVUAR
Date   Source Headline
5th Dec 20177:00 amRNSNorth America Update
13th Nov 20171:37 pmRNSHolding(s) in Company
8th Nov 201711:19 amRNSHolding(s) in Company
7th Nov 20177:00 amRNSTrading Update
3rd Nov 201712:46 pmRNSBlock listing Interim Review
17th Aug 20179:24 amRNSHolding(s) in Company
31st Jul 20174:50 pmRNSHolding(s) in Company
26th Jul 20177:00 amRNSDirector/PDMR Shareholding
25th Jul 201712:03 pmRNSHolding(s) in Company
25th Jul 20177:00 amRNSInterim Results
25th May 20177:00 amRNSResult of Placing in Fevertree Drinks PLC
24th May 20174:35 pmRNSProposed placing of shares in Fevertree Drinks PLC
18th May 20177:00 amRNSGrant of Options
15th May 20175:05 pmRNSResult of AGM
15th May 20177:00 amRNSAGM Statement
25th Apr 201711:05 amRNSHolding(s) in Company
5th Apr 20177:00 amRNS2016 Annual Report and Notice of AGM
21st Mar 20177:00 amRNSPreliminary Results
27th Feb 20172:39 pmRNSHolding(s) in Company
17th Feb 201712:50 pmRNSHolding(s) in Company
30th Jan 201712:37 pmRNSHolding(s) in Company
27th Jan 20174:57 pmRNSHolding(s) in Company
24th Jan 20172:35 pmRNSHolding(s) in Company
24th Jan 20177:00 amRNSTrading Update
15th Nov 20169:31 amRNSHolding(s) in Company
11th Nov 20162:13 pmRNSHolding(s) in Company
7th Nov 20163:58 pmRNSHolding(s) in Company
7th Nov 20167:00 amRNSTrading Statement
26th Oct 20163:35 pmRNSHolding(s) in Company
20th Oct 20165:46 pmRNSHolding(s) in Company
30th Aug 20162:32 pmRNSHolding(s) in Company
26th Aug 20168:21 amRNSHolding(s) in Company
24th Aug 20169:42 amRNSHolding(s) in Company
23rd Aug 20164:59 pmRNSHolding(s) in Company
23rd Aug 20161:35 pmRNSHolding(s) in Company
19th Aug 20162:34 pmRNSHolding(s) in Company
18th Aug 20168:33 amRNSHolding(s) in Company
17th Aug 20169:56 amRNSHolding(s) in Company
5th Aug 201610:02 amRNSHolding(s) in Company
29th Jul 20163:49 pmRNSHolding(s) in Company
26th Jul 20167:00 amRNSInterim Results
8th Jun 20165:05 pmRNSHolding(s) in Company
6th Jun 20165:17 pmRNSHolding(s) in Company
26th May 20167:00 amRNSGrant of Options
19th May 20167:00 amRNSTrading Update
21st Apr 20165:48 pmRNSResult of AGM
24th Mar 20167:00 amRNSDirector/PDMR Shareholding
22nd Mar 201610:00 amRNS2015 Annual Report and Notice of AGM
14th Mar 20167:00 amRNSPreliminary Results
29th Feb 20165:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.